JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Search results for: '4 hqn'

Search results for: '4 hqn'

A4117 AT9283

Summary: Aurora kinase/JAK inhibitor

insoluble in H2O; ≥19.05 mg/mL
F1935 Anti-CD3 & EpCAM Antibody (Catumaxomab (Catumaxomab (huIgG1-rat IgG2b))

Summary: Anti-CD3 & EpCAM Antibody (Catumaxomab (Catumaxomab (huIgG1-rat IgG2b))
P1156 Recombinant Human BMP-4

Summary: Bone Morphogenetic Protein 4 is one of the BMPs, some of which belong to the TGF-beta superfamily (BMP2-7).
BA3442 PKUMDL-LC-101-D04

Summary: PKUMDL-LC-101-D04 (GPX4-Activator-1d4) is a potent iron death regulator glutathione peroxidase 4 variant activator (=4.7).

≥50.8 mg/mL
K2149 Caspase Colorimetric Substrate Set II Plus

Summary: Set of 9: Caspase-1, 2, 3, 4, 5, 6, 8, 9 & 10 Substrates.
BA5484 Xanomeline

Summary: Xanomeline increases neuronal excitability as a potent selective muscarinic type 1 and type 4 receptor agonist.
BA5507 VU0467485

Summary: VU0467485 (AZ13713945) is a potent, selective, orally bioavailable muscarinic acetylcholine receptor 4 orthosteric modulator (PAM).
BA5945 Botensilimab

Summary: Botensilimab (AGEN1181) is a human anti-cytotoxic T-lymphocyte antigen 4 monoclonal antibody, an innate and adaptive immune activator.
BA7017 GSK2798745

Summary: GSK2798745 is a potent, selective and orally active transient receptor potential vanilloid 4 ion channel blocker.
A5719 AT7519

Target: Cyclin-Dependent Kinases

Summary: Multi-CDK inhibitor